- About Us
- Services & Solutions
- Novel Technology Platform
- Bioconjugation Discovery
- Bioconjugation Process Development
- Analytical Development
- Formulation and DP Development
- GMP mAb Intermediate and Conjugation Manufacturing
- GMP Formulation, Fill and Lyophilization
- Payload and Linker R&D and Manufacturing
- Ready-Made Payloads & Linkers
- WuXi XDC Singapore Site
- Investor Relations
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Payload-Linkers for ADCs: Late-Stage CMC Strategies, Risk Assessment, PPQ and GMP Manufacturing
Antibody-Peptide Conjugates and WuXi XDC’s capability in APCs
Antibody-Peptide Conjugates (APCs), riding the booming wave of global peptide therapeutics, harness antibodies’ precise targeting to deliver therapeutic peptides directly to diseased cells. Combining antibodies’ exquisite specificity with the potent pharmacological...Integrated Bioconjugate Discovery Services at WuXi XDC
Driving Dual-Payload ADC (dp-ADC) Development with Proprietary WuXiDARx™, X-LinC, and WuXiTecan-2
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?